The reduced level of irisin in human milk may have negative effects on infant weight and lipid regulation [101], while Mól and coworkers [102] reported that altered concentrations of irisin and visfatin in milk from preterm delivered mothers might eventually lead to a higher risk for metabolic disorders in prematurely born children in later years. Here, NAMPT is linked to metabolic disease.